Literature DB >> 21851856

The effects of APOE on the functional architecture of the resting brain.

Aaron J Trachtenberg1, Nicola Filippini, Klaus P Ebmeier, Steve M Smith, Fredrik Karpe, Clare E Mackay.   

Abstract

There is a well-established association between APOE genotype and the risk of developing Alzheimer's disease (AD). Relative to individuals with the common ε3/ε3 genotype, carriers of the ε4 allele are at increased risk of developing AD, while carriers of the ε2 allele appear to be protected against the disease. However, we recently reported that in a sample of cognitively healthy adults, both ε4 and ε2 carriers showed nearly identical changes in the pattern of fMRI activity during memory and non-memory tasks, relative to ε3 homozygotes. These findings suggest that the effects of APOE on brain function are not tightly linked to the effects of this gene on AD risk. Here we test the hypothesis that APOE has an intrinsic effect on the brain's functional networks. Resting-state fMRI was used to compare the pattern of functional connectivity of a variety of resting-state networks between 77 cognitively healthy participants aged 32 to 55 with different APOE genotypes (23 ε2/ε3, 20 ε3/ε3, 26 ε3/ε4, and 8 ε4/ε4). Differences between genotype groups were found in two hippocampal networks, the auditory network, the left frontal-parietal network, and the lateral visual network. While there was considerable variety in the brain regions affected and the direction of change across networks, the main finding was that changes in functional connectivity were similar in ε4 and ε2 carriers, relative to ε3 homozygotes. APOE appears to have an intrinsic effect on the differentiation of functional networks in the brain. This effect is apparent in cognitively healthy adults and does not manifest in a manner reflective of the link between APOE and AD risk. Rather, the effects of APOE on brain function may relate to the role of this gene in neurodevelopment.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21851856     DOI: 10.1016/j.neuroimage.2011.07.059

Source DB:  PubMed          Journal:  Neuroimage        ISSN: 1053-8119            Impact factor:   6.556


  55 in total

1.  A combined effect of two Alzheimer's risk genes on medial temporal activity during executive attention in young adults.

Authors:  Adam E Green; Jeremy R Gray; Colin G Deyoung; Timothy R Mhyre; Robert Padilla; Amanda M Dibattista; G William Rebeck
Journal:  Neuropsychologia       Date:  2014-01-02       Impact factor: 3.139

2.  Longitudinal change in working memory as a function of APOE genotype in midlife and old age.

Authors:  Pamela M Greenwood; Thomas Espeseth; Ming-Kuan Lin; Ivar Reinvang; Raja Parasuraman
Journal:  Scand J Psychol       Date:  2014-06

3.  Adaptive testing for multiple traits in a proportional odds model with applications to detect SNP-brain network associations.

Authors:  Junghi Kim; Wei Pan
Journal:  Genet Epidemiol       Date:  2017-02-13       Impact factor: 2.135

4.  Opposite Neural Trajectories of Apolipoprotein E ϵ4 and ϵ2 Alleles with Aging Associated with Different Risks of Alzheimer's Disease.

Authors:  Hao Shu; Yongmei Shi; Gang Chen; Zan Wang; Duan Liu; Chunxian Yue; B Douglas Ward; Wenjun Li; Zhan Xu; Guangyu Chen; Qihao Guo; Jun Xu; Shi-Jiang Li; Zhijun Zhang
Journal:  Cereb Cortex       Date:  2014-10-21       Impact factor: 5.357

Review 5.  Neuroimaging and other biomarkers for Alzheimer's disease: the changing landscape of early detection.

Authors:  Shannon L Risacher; Andrew J Saykin
Journal:  Annu Rev Clin Psychol       Date:  2013-01-07       Impact factor: 18.561

6.  Multimodal characterization of older APOE2 carriers reveals selective reduction of amyloid load.

Authors:  Michel J Grothe; Sylvia Villeneuve; Martin Dyrba; David Bartrés-Faz; Miranka Wirth
Journal:  Neurology       Date:  2017-01-06       Impact factor: 9.910

Review 7.  Apolipoprotein E, gender, and Alzheimer's disease: an overlooked, but potent and promising interaction.

Authors:  Leo Ungar; Andre Altmann; Michael D Greicius
Journal:  Brain Imaging Behav       Date:  2014-06       Impact factor: 3.978

Review 8.  APOE and neuroenergetics: an emerging paradigm in Alzheimer's disease.

Authors:  Andrew B Wolf; Richard J Caselli; Eric M Reiman; Jon Valla
Journal:  Neurobiol Aging       Date:  2012-11-16       Impact factor: 4.673

Review 9.  Neuroimaging biomarkers of neurodegenerative diseases and dementia.

Authors:  Shannon L Risacher; Andrew J Saykin
Journal:  Semin Neurol       Date:  2013-11-14       Impact factor: 3.420

Review 10.  Genetics of the connectome.

Authors:  Paul M Thompson; Tian Ge; David C Glahn; Neda Jahanshad; Thomas E Nichols
Journal:  Neuroimage       Date:  2013-05-21       Impact factor: 6.556

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.